The Top 50 Global Pharma Companies 2013

The Pharmaceutical Executive magazine published its annual ranking of the Top 50 Pharma Companies Worldwide based on sales earlier this month. New York -based Pfizer(PFE) was topped the list with a sales of over $47.4 billion in 2012.

The Top 50 Global Pharma Companies are listed in the tables below:

Click to enlarge

1-Part-Top-50-Pharma-Companies-2013

2-Part-Top-50-Pharma-Companies-2013

Source: Pharmaceutical Executive

Here are a few observations:

  • Swiss drug giant Novartis(NVS) came in at number two with sales of over $45.0 billion.
  • Among the top 10, five are European pharma companies including Novartis, Sanofi (SNY), Roche (RHHBY), GlaxoSmithkline(GSK), and Astrazeneca (AZN).
  • Teva (TEVA) of Israel, the world’s largest generic maker had revenues of sales of over $17.0 billion and took the 11th spot. Teva’s growth so far has been astonishing and is now within striking distance of taking the 10th rank from Eli Lilly(LLY).
  • For the first time, Indian pharma maker Ranbaxy Laboratories appears in this top 50 list. Ranbaxy is majority-owned by Daiichi Sankyo of Japan.
  • For the first time in more than 50 years, year-on-year growth contracted in the U.S. market due to patent expiration of blockbusters such as Plavix, Seroquel, Lipitor, and Zyprexa and increased scrutiny of pricing by payers and regulatory approvals.
  • Due to the ongoing recession, growth in Europe was flat.
  • Fresenius is a leader in the dialysis market. Its Medical Care division trades on the NYSE under the ticker FMS.

Disclosure: No Positions

Also checkout: The Top 50 Global Pharma Companies 2014

Update:

Download: The Top 50 Global Pharma Companies 2012 (in pdf)

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>